CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Han Biomedical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Han Biomedical Inc
Phone: +886 226971328p:+886 226971328 NEW TAIPEI, 221  Taiwan Ticker: 69996999

Business Summary
Han Biomedical Inc is a Taiwan-based company that designs, develops and produces medical materials for tissue reconstruction and repair using natural biomedical materials. Its main products include BarriGel, a post-surgical anti-adhesion product that extends the degradation time to prevent post-surgical adhesion complications. Its product also includes Hancare, a collagen scaffolding material made from self-purified, high-quality, medical-grade collagen that easily adheres to wounds and quickly absorbs exudate. The Company is also engaged in the design and development of healthcare products. The Company distributes its products mainly to the domestic market.
(Source: N-30D)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023-----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Head of Finance & Accounting FutaiLi 8/8/2024 8/8/2024

General Information
Outstanding Shares: 18,978,518 (As of 10/4/2024)
Stock Exchange: TPO
Fax Number: +886 226971269


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024